Patent · US Active

Method and medicament for inhibiting the expression of a given gene

US8183362B2 · kind B2 · utility

6Cited by

72References

16Claims

0Family size

Assignee

Alnylam Pharmaceuticals, Inc. · US

Inventors

Roland Kreutzer · Weidenberg, DE
Stefan Limmer · Neudrossenfeld, DE

Key dates

Filing date	Oct 31, 2007
Grant date	May 22, 2012
Priority date	—
Expiry date	Sep 2, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.